Promising preclinical cancer therapy harnesses newly discovered cell death pathway
Thirumala-Devi Kanneganti, PhD, St. Jude Department of Immunology, and Rajendra Karki, PhD, St. Jude Immunology, led research that found interactions
Source: miragenews.com